Additionally, CSF2 serves as a shared target among colorectal cancer, breast cancer, Ewing’s sarcoma, melanoma, ovarian cancer, soft tissue sarcoma, and solid tumors. This evidence concerns the gene CSF2 and soft tissue sarcoma.